Steris (STE)Rep. April McClain Delaney (MD06) disclosed a partial sale $1K–$15K
Rep. April McClain Delaney (MD06) disclosed a partial sale of Steris in the $1K–$15K range.
- $1,001–$15,000
- Reported range · official band, not an exact amount
- 3 days
- Disclosure lag
- Traded
- Jul 31, 2026
- Disclosed
- Aug 3, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 7, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On July 31, 2026, Pierre Boulud was appointed to serve on the Audit Committee of the Board and the Compliance and Technology Committee of the Board.”
- May 11, 2026Congress · 1 personMembers of Congress: 2 purchases
- May 13, 2026CongressDisclosed purchase of STE — reported range $1,001 - $15,000
- Jun 2, 2026InsiderDirector sold ~$310K of STE shares in the open market
- Jun 4, 2026InsiderCEO sold ~$656K of STE shares in the open market
- Jun 5, 2026InsiderCEO sold ~$291K of STE shares in the open market
- Jun 15, 2026InsiderOfficer sold ~$297K of STE shares in the open market
- Jun 24, 2026FDAFDA device clearance: AMSCO 700 Steam Sterilizer
- Jul 13, 2026CongressDisclosed sale of STE — reported range $1,001 - $15,000
- Jul 24, 2026CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
- Jul 27, 2026CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
- Jul 29, 2026CongressDisclosed partial sale of STE — reported range $1,001 - $15,000
- Jul 31, 2026 · this disclosureCongressDisclosed partial sale of STE — reported range $1,001 - $15,000
What came next
- Aug 5, 2026Company filing · Form 8-K · Results, RestructuringAnnounced job cuts, closures or a restructuring, and reported its results“On August 5, 2026, the Company announced a targeted consolidation plan (the “Consolidation Plan”) to consolidate existing manufacturing and distribution for formulated chemistries to a new Center of Excellence in North Carolina.”
- Aug 12, 2026InsiderDirector sold ~$957K of STE shares in the open market
- Aug 25, 2026CongressDisclosed sale of STE — reported range $100,001 - $250,000
- Sep 15, 2026CongressDisclosed sale of STE — reported range $15,001 - $50,000
How to read House Clerk periodic transaction report
The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.
Full guide: What is the STOCK Act?
What else is on file for Steris
For Steris, OQRO holds 1 insider filing (SEC Form 4 or Form 144), 7 Congress trade reports and 18 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its STE page.
Other recent filings by Rep. April McClain Delaney (MD06)
- House Clerk periodic transaction report at Corpay (CPAY)Sep 9, 2026
- House Clerk periodic transaction report at Middleby (MIDD)Sep 9, 2026
- House Clerk periodic transaction report at Tractor Supply (TSCO)Sep 9, 2026
- House Clerk periodic transaction report at Wabtec (WAB)Sep 9, 2026
- House Clerk periodic transaction report at Wabtec (WAB)Sep 9, 2026
The full history of Rep. April McClain Delaney (MD06) is on the profile page.
How this filing works
Other disclosures at Steris
- House Clerk periodic transaction reportSep 25, 2026
- House Clerk periodic transaction reportSep 9, 2026
- House Clerk periodic transaction reportAug 27, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRAug 14, 2026
Everything OQRO holds on this company is on its STE page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
